Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 14/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | CASP7 | P55210 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17706596 | 1.00 | ADRB2 (0.55) | ADRB2HIF1ATSHRADRA1ALMNA | |
| SCHEMBL10784137 | 0.84 | LMNA (0.59) | ADRB2HIF1ATSHRADRA1ALMNA | |
| SCHEMBL22528201 | 0.79 | ADRB2 (0.67) | ADRB2HIF1ATSHRADRA1ALMNA | |
| SCHEMBL2986684 | 0.78 | HKDC1 (0.52) | ADRB2HIF1ATSHRADRA1ALMNA | |
| SCHEMBL12610310 | 0.78 | LMNA (0.66) | ADRB2HIF1ATSHRADRA1ALMNA | |
| SCHEMBL2978589 | 0.78 | LMNA (0.66) | ADRB2HIF1ATSHRADRA1ALMNA | |
| SCHEMBL31094667 | 0.78 | LMNA (0.66) | ADRB2HIF1ATSHRADRA1ALMNA | |
| SCHEMBL31544929 | 0.77 | ESR1 (0.58) | ADRB2HIF1ATSHRADRA1ALMNA | |
| SCHEMBL13232126 | 0.76 | ADRB2 (0.71) | ADRB2HIF1ATSHRADRA1ACYP3A4 | |
| SCHEMBL28930578 | 0.76 | ADRB2 (0.66) | ADRB2HIF1ATSHRADRA1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1561791-B1 | New ink compositions for ink jet printing | AGFA GRAPHICS NV (BE) | 2016-03-16 | — | — | EP | disclosed |
| US-7777073-B2 | Topical delivery system for antiaging and skin whitening agents | BIODERM RESEARCH (US) | 2010-08-17 | — | — | US | disclosed |
| US-RE40847-E1 | Ink compositions for ink jet printing | AGFA-GEVAERT (BE) | 2009-07-14 | — | — | US | disclosed |
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | BIODERM RESEARCH (US) | 2009-03-19 | — | — | US | disclosed |
| US-7297460-B2 | Radiation curable ink compositions suitable for ink-jet printing | AGFA-GEVAERT (BE) | 2007-11-20 | — | — | US | disclosed |
| EP-1422275-B1 | Fast drying jet ink composition | VIDEOJET TECHNOLOGIES INC (US) | 2007-06-27 | — | — | EP | disclosed |
| EP-1452569-B1 | Radiation curable ink compositions suitable for ink-jet printing. | AGFA GEVAERT (BE) | 2007-01-10 | — | — | EP | disclosed |
| EP-1561792-B1 | New ink compositions for ink jet printing | AGFA GEVAERT (BE) | 2006-08-30 | — | — | EP | disclosed |
| EP-1344805-B1 | New ink compositions for ink jet printing | AGFA GEVAERT (BE) | 2005-12-21 | — | — | EP | disclosed |
| US-20050277708-A1 | Ink compositions for ink jet printing | AGFA-GEVAERT (BE) | 2005-12-15 | — | — | US | disclosed |
| WO-1997003137-A2 | A JET INK PRINTING INK COMPOSITION | THE GENERAL ELECTRIC COMPANY PLC (GB) | 1997-01-30 | — | — | WO | disclosed |
| US-5596027-A | CARRIER, POLYAMINE, COLORANT, ACIDIC RESIN | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1997-01-21 | — | — | US | disclosed |
| US-5332640-A | Toner compositions with dendrimer charge enhancing additives | XEROX CORPORATION (US) | 1994-07-26 | — | — | US | disclosed |
| EP-0604097-A1 | Ink compositions | XEROX CORPORATION (US) | 1994-06-29 | — | — | EP | disclosed |
| US-5266106-A | Ink compositions with dendrimer grafts | XEROX CORPORATION (US) | 1993-11-30 | — | — | US | disclosed |
| US-5256193-A | Porphyrin chromophore and dendrimer ink composition | XEROX CORPORATION (US) | 1993-10-26 | — | — | US | disclosed |
| US-5256516-A | Toner compositions with dendrimer charge enhancing additives | XEROX CORPORATION (US) | 1993-10-26 | — | — | US | disclosed |
| US-5254159-A | Mixture of water, anionic dye and polyamine | XEROX CORPORATION (US) | 1993-10-19 | — | — | US | disclosed |
| US-5120361-A | Aqueous solution comprised of dyes and star polymers with dendritic branches | XEROX CORPORATION (US) | 1992-06-09 | — | — | US | disclosed |
| US-5098475-A | Inks with dendrimer colorants | XEROX CORPORATION (US) | 1992-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | TYR, MMP17, MMP1 | ADRB2 1017/4885HIF1A 2476/4885TSHR 2624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.